 |
recombinant multimerized human IgG1 Fc |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic inflammatory demyelinating polyneuropathy |
| USA Market Approval | USA |
| USA Designation Date | 2015-07-14 00:00:00 |
| Sponsor | Pfizer, Inc.;500 Arcola Road;Collegeville, Pennsylvania, 19426 |
